title: Documentation of thyroid function in clinical studies with sunitinib: why does it matter?
authors.forename: David H
authors.initials: DH
authors.lastname: Garfield
authors.forename: Pascal
authors.initials: P
authors.lastname: Wolter
authors.forename: Patrick
authors.initials: P
authors.lastname: Schöffski
authors.forename: Aleck
authors.initials: A
authors.lastname: Hercbergs
authors.forename: Paul
authors.initials: P
authors.lastname: Davis
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007037:Hypothyroidism / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D007211:Indoles / Q000009:adverse effects*; D008297:Male; D009369:Neoplasms / Q000098:blood supply / Q000188:drug therapy*; D011758:Pyrroles / Q000009:adverse effects*; D000077210:Sunitinib; D013960:Thyroid Function Tests; D016896:Treatment Outcome
chemical_list: D020533:Angiogenesis Inhibitors; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib